)
Visual24 Oct 2025
The rise of Alphabet
Abliva (ABLI) investor relations material
Abliva Q4 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2024 earnings summary21 Feb, 2025
Executive summary
Positive interim analysis of the FALCON study with KL1333 increased likelihood of successful final results and attracted significant industry attention.
Pharming Technologies B.V. launched a public cash offer for Abliva, accepted by over 90% of shareholders by February 2025.
KL1333 advanced as the lead candidate for adult mitochondrial disease, with all Wave 1 patients completing the FALCON study and EMA approval of the Pediatric Investigation Plan.
Capital raised through a fully guaranteed rights issue and convertible bonds, totaling approximately SEK 88 million.
NV354 remains in preclinical phase with no major operational activities planned due to KL1333 prioritization.
Financial highlights
Net revenues for 2024 were SEK 0, down from SEK 137,000 year-over-year; other operating income was SEK 497,000 (1,345,000).
Full-year operating loss was SEK 91,014,000, improved from SEK 96,548,000 year-over-year.
Loss before tax for 2024 was SEK 89,954,000, compared to SEK 95,518,000 in 2023.
Loss per share before and after dilution was SEK 0.07 (0.09) for the year.
Cash and cash equivalents at year-end were SEK 32,670,000, down from SEK 57,664,000.
Outlook and guidance
Wave 2 of the FALCON study with KL1333 is set to commence in 2025.
Pharming's acquisition is expected to provide financial stability and resources for further development and commercialization.
No dividend proposed for 2024.
Explain the strategic advisors' evaluation.
Detail the objectives for Wave 2 of FALCON.
How does NV354 restore energy to the cell?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Abliva is a biopharmaceutical company focused on developing therapies for primary mitochondrial diseases. It specializes in novel treatments targeting energy metabolism disorders. The company is headquartered in Lund, Sweden, and its shares are listed on the Nasdaq Stockholm.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage